Elevance Health Inc. Profile Avatar - Palmy Investing

Elevance Health Inc.

Elevance Health Inc. operates as a health benefits company. It supports consumers, families, and communities across the entire care journey connecting to the care, support, and resources to lead healthier lives. It serves approximately 118 million people…
Medical - Healthcare Plans
US, Indianapolis [HQ]

FA

Fundamental Analysis · Most Recent Quarter

It is important to understand the FA Algorithm and the criterias before valuing it as a top-tier resource.

Read Rationale
Framework:
Valuation 56% Somewhat Positive
Profitability n.A. n.A.
Fin. Growth 67% Positive
Leverage & Liquidity 50% Balanced
Per Share Metrics 33% Weak
Fin. Health n.A. n.A.
Fundamentals

Valuation

Metric Q4 Q1 Δ in %
EV/EBITDA -98.55 4.14 286.19
Graham Fair Price 64.91 194.67 118.05
PEG -91.56 0.08 -0.97
Price/Book 5.75 2.96 2.80
Price/Cash Flow 112.01 70.67 -33.34
Prices/Earnings -58.36 13.37 32.10
Price/Sales 9.43 2.82 2.58
Price/FCF 112.01 70.67 -33.34
Naive Interpretation member
01 - Valuation · Somewhat Positive
Fundamentals

Profitability

Metric Q4 Q1 Δ in %
Gross Profit Margin 2.66 0.91 0.89
Operating Margin 135586.71 0.80 < 0.005
ROA 155.43 0.02 < 0.005
ROE 0.02 0.06 153.97
ROIC < 0.005 0.39 119863.99
Naive Interpretation member
02 - Profitability · Not Interpreted
Fundamentals

Financial Growth

Metric Q4 Q1 Δ in %
Debt QOQ 0.05 0.01 376.95
Dividends QOQ < 0.005 0.10 2482.26
EBIT QOQ -0.98 1353.64 137341.41
EPS QOQ -0.33 1.63 393.33
FCF QOQ -2.44 1.52 -37.83
Revenue QOQ < 0.005 < 0.005 65.18
Naive Interpretation member
03 - Financial Growth · Positive
Fundamentals

Leverage & Liquidity

Metric Q4 Q1 Δ in %
Assets Turnover n.A. n.A. n.A.
Days Inventory Outstanding (DIO) -1004.85 -1271.74 -26.56
Days Sales Outstanding (DSO) 37.70 38.67 2.56
Inventory Turnover -0.09 -0.07 20.99
Debt/Capitalization 0.39 0.39 1.16
Quick Ratio 1.29 1.23 -4.77
Naive Interpretation member
04 - Leverage & Liquidity · Balanced
Fundamentals

Per Share Metrics

Metric Q4 Q1 Δ in %
Book Value 168.64 174.51 3.48
Cash 155.06 155.85 0.51
Capex -1.40 -1.20 14.28
Free Cash Flow -14.15 7.30 -48.39
Revenue 182.98 182.97 < 0.005
Naive Interpretation member
05 - Per Share Metrics · Weak
Fundamentals

Financial Health

Metric Q4 Q1 Δ in %
Current Ratio 1.44 1.37 -4.29
Debt/Assets n.A. n.A. n.A.
Debt/Equity n.A. n.A. n.A.
Net Debt/EBITDA 41.41 0.60 -98.56
Naive Interpretation Member
06 - Financial Health · Weak
End of ELV's Analysis
CIK: 1156039 CUSIP: 036752103 ISIN: US46138E2972 LEI: - UEI: -
Secondary Listings